Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Szer, Jeff  [Clear All Filters]
Journal Article
Yoshimi A, Baldomero H, Horowitz M, Szer J, Niederwieser D, Gratwohl A, Kodera Y. Global Use of Peripheral Blood vs Bone Marrow as Source of Stem Cells for Allogeneic Transplantation in Patients With Bone Marrow Failure. JAMA. 2016;315(2):198-200.
Szer J, Weisdorf D, Querol S, Foeken L, Madrigal A. The impact of COVID-19 on the provision of donor hematopoietic stem cell products worldwide: collateral damage. Bone Marrow Transplant. 2020.
Hillmen P, Szer J, Weitz I, Röth A, Höchsmann B, Panse J, Usuki K, Griffin M, Kiladjian J-J, de Castro C, et al. Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2021;384(11):1028-1037.
Douglas AP, Yu L, Sundararajan V, Szer J, Ritchie D, Slavin MA, Sasadeusz J, Visvanathan K. The QuantiFERON Monitor Assay is predictive of infection post allogeneic hematopoietic cell transplant. Transpl Infect Dis. 2020:e13260.
Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, et al. Real-world issues and potential solutions in HCT during the COVID-19 pandemic: Perspectives from the WBMT and the CIBMTR's Health Services and International Studies Committee. Biol Blood Marrow Transplant. 2020.
Curran D, Matthews S, Rowley SD, Young J-AH, Bastidas A, Anagnostopoulos A, Barista I, Chandrasekar PHaran, Dickinson M, Idrissi MEl, et al. Recombinant zoster vaccine significantly reduces the impact on quality of life caused by herpes zoster in adult autologous hematopoietic stem cell transplant recipients: a randomized placebo-controlled trial (ZOE-HSCT). Biol Blood Marrow Transplant. 2019.
Zeiser R, von Bubnoff N, Butler J, Mohty M, Niederwieser D, Or R, Szer J, Wagner EM, Zuckerman T, Mahuzier B, et al. Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease. N Engl J Med. 2020.
Szer J, Elmoazzen H, Fechter M, Hwang W, Korhonen M, Miller J, Mengling T, Shaw B, Stein J. Safety of Living Donation of Hematopoietic Stem Cells. Transplantation. 2016.
Szer J. Is there no place like home for an allogeneic stem cell transplant?. Bone Marrow Transplant. 2020.
Lim ABM, Roberts AW, Mason K, Bajel A, Szer J, Ritchie DS. Validating the Allogeneic Stem Cell Transplantation Disease Risk Index: Sample Size, Follow-up, and Local Data Are Important. Transplantation. 2014.